State Board of Administration of Florida Retirement System’s Kalaris Therapeutics KLRS Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio KLRS Stock Details KLRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-575	Closed	-$8.99K	–	2488
2023 Q4	$8.99K	Buy	+575	New	+$22.7K	﹤0.01%	2427
2023 Q3	–	Sell	-517	Closed	-$40.5K	–	2417
2023 Q2	$40.5K	Buy	+517	New	+$49.1K	﹤0.01%	2403

Other funds holding KLRS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Board of Administration of Florida Retirement System's KLRS Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Kalaris Therapeutics (KLRS) in Q1 2024, closing a stake of 575 shares — an estimated $8.99K sold.

State Board of Administration of Florida Retirement System first reported a position in KLRS in Q2 2023 and held it in 2 quarters. The position peaked at $40.5K in Q2 2023. 76 funds tracked by Wall St. Rank hold KLRS as of Q1 2024.

State Board of Administration of Florida Retirement System reported no remaining Kalaris Therapeutics position as of Q1 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 575 Kalaris Therapeutics shares in Q1 2024, an estimated $8.99K.
State Board of Administration of Florida Retirement System first reported a position in Kalaris Therapeutics in Q2 2023 and held it in 2 quarters.
State Board of Administration of Florida Retirement System's Kalaris Therapeutics position peaked at $40.5K in Q2 2023.
76 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.